Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia

NCT00170196 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2008-09-29

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of addition of corticosteroid therapy to antibiotics in patient admitted with Community-acquired pneumonia.

The hypothesis is: Prednisolone in combination with antibiotic treatments is effective in improving clinical outcome in patients hospitalized with CAP.

Conditions

Interventions

DRUG

prednisone

Sponsors & Collaborators

  • Medical Center Alkmaar

    lead OTHER

Principal Investigators

  • Dominic Snijders, Drs · Pulmo Science

  • Wim G Boersma, dr · Pulmo Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2008-08-31
Completion
2008-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00170196 on ClinicalTrials.gov